...
首页> 外文期刊>Folia histochemica et cytobiologica >Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
【24h】

Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.

机译:晚期胃癌Ki-67,PCNA和MCM2蛋白增殖指数(PI)的免疫组织化学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

The current study objective was to assess the proliferation indices (PI) of Ki-67, PCNA and MCM2 proteins in advanced gastric cancer and in metastatic lymph node in correlation with certain clinicopathological features and with postoperative survival of patients. The study was conducted in a group of 100 patients with advanced gastric cancers. Involvement of local lymph nodes was present in 36 cases. Immunohistochemical investigations were carried out using monoclonal antibodies against Ki-67 (DAKO), PCNA (DAKO) and polyclonal antibody to MCM2 (Santa Cruz Biotechnology). Visualization of the antigen/antibody complex was performed using LSAB technique (biotin-streptavidin-peroxidase) followed by application of chromogene DAB (DAKO). Statistical analysis revealed no correlations of Ki-67, PCNA and MCM2 PI in tumour tissue or metastatic lymph node with patients' age and gender, tumour location, histological grade, macroscopic type according to Bormann's classification and histological grading by Lauren's and Goseki's classifications. Moreover, no correlation was observed of Ki-67 and MCM2 PI in tumour tissue with histological grading. No correlation was also noted between the proliferation indices of all the three proteins in the affected lymph node and grade of histological differentiation. Such clinicopathological parameters as patients' age and gender, histological grading by Lauren's and Goseki's classifications and lymph node involvement did not correlate with survival time of patients. Furthermore, no statistically significant correlation was shown of postoperative survival time with Ki-67 and MCM2 PI in tumour tissue and metastatic lymph nodes and with PCNA PI in the affected lymph nodes. However, a statistically significant correlation was found of Ki-67, PCNA and MCM2 PI in tumour tissue and metastatic lymph nodes with depth of wall invasion and local lymph node involvement. A statistically significant correlation was also noted between PCNA PI in the main mass of tumour and histological grading. The postoperative survival time of patients exhibited a statistically significant correlation with tumour location and macroscopic type according to Bormann's classification. Correlations on statistical borderline were noted between survival time and depth of gastric wall invasion and PCNA PI in the main mass of tumour.
机译:当前的研究目标是评估与某些临床病理特征和患者术后存活率相关的晚期胃癌和转移性淋巴结中Ki-67,PCNA和MCM2蛋白的增殖指数(PI)。该研究是在一组100例晚期胃癌患者中进行的。局部淋巴结受累36例。使用针对Ki-67的单克隆抗体(DAKO),PCNA(DAKO)和针对MCM2的多克隆抗体(Santa Cruz Biotechnology)进行了免疫组织化学研究。使用LSAB技术(生物素-链霉亲和素-过氧化物酶)进行抗原/抗体复合物的可视化,然后使用发色团DAB(DAKO)。统计分析显示,根据Bormann分类法和根据Lauren's和Goseki分类法进行的组织学分级,肿瘤组织或转移性淋巴结中Ki-67,PCNA和MCM2 PI与患者的年龄和性别,肿瘤位置,组织学等级,宏观类型无关。此外,在肿瘤组织中未观察到Ki-67和MCM2 PI与组织学分级的相关性。在受影响的淋巴结中所有三种蛋白质的增殖指数与组织学分化程度之间也没有相关性。诸如患者的年龄和性别,Lauren's和Goseki's分类的组织学分级以及淋巴结受累等临床病理参数与患者的生存时间无关。此外,在肿瘤组织和转移性淋巴结中与Ki-67和MCM2 PI以及在受影响的淋巴结中与PCNA PI的术后生存时间无统计学意义的相关性。然而,在肿瘤组织和转移性淋巴结中,Ki-67,PCNA和MCM2 PI与壁浸润深度和局部淋巴结受累程度之间存在统计学上的显着相关性。肿瘤主要肿块中PCNA PI与组织学分级之间也有统计学意义的相关性。根据Bormann的分类,患者的术后生存时间与肿瘤位置和宏观类型有统计学意义的相关性。生存时间与胃壁浸润深度和主要肿瘤肿块中PCNA PI之间的统计学界限相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号